Squadron Capital Management Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$272.9M
Q ending 2026-03-31
Prior quarter
$236.0M
Q ending 2025-12-31
Change
+15.7% QoQ
Positions
37
reported holdings
Largest positions
All 37 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Relmada Therapeutics Inc | RLMD | Shares | $59.0M | 8.5M |
| Cogent Biosciences Inc | COGT | Shares | $30.3M | 787K |
| Kalvista Pharmaceuticals Inc | 4XC1 | Shares | $19.8M | 985K |
| Kodiak Sciences Inc | KOD | Shares | $14.5M | 380K |
| Abivax Sa | ABVX | Shares | $14.5M | 130K |
| Edgewise Therapeutics Inc | EWTX | Shares | $11.0M | 350K |
| Nektar Therapeutics | NKTR | Shares | $9.0M | 125K |
| Adlai Nortye Ltd | ANL | Shares | $8.8M | 1.3M |
| Zentalis Pharmaceuticals Inc | ZNTL | Shares | $8.5M | 3.6M |
| Maze Therapeutics Inc | MAZE | Shares | $7.7M | 258K |
| Scynexis Inc | SCYXEUR | Shares | $7.0M | 7.6M |
| Relay Therapeutics Inc | RLAY | Shares | $6.7M | 673K |
| Kalvista Pharmaceuticals Inc | 4XC1 | Call | $6.3M | 315K |
| C4 Therapeutics Inc | CCCC | Shares | $5.9M | 2.3M |
| Inhibikase Therapeutics Inc | IKT | Shares | $5.9M | 3.5M |
| Palisade Bio Inc | PALI | Shares | $5.3M | 3.0M |
| Eupraxia Pharmaceuticals Inc | EPRX | Shares | $4.9M | 680K |
| Gh Research Plc | Shares | $4.6M | 325K | |
| Karyopharm Therapeutics Inc | KPTI | Put | $4.2M | 750K |
| Promis Neurosciences Inc | PMN | Shares | $4.1M | 325K |
| Ideaya Biosciences Inc | IDYA | Put | $4.0M | 120K |
| Lipocine Inc New | LPCN | Shares | $3.6M | 450K |
| Ideaya Biosciences Inc | IDYA | Call | $3.5M | 104K |
| Inventiva Sa | IVA | Shares | $3.0M | 535K |
| Alx Oncology Hldgs Inc | ALXO | Shares | $2.9M | 1.5M |
| Context Therapeutics Inc | CNTX | Shares | $2.9M | 1.1M |
| Nextcure Inc | NXTC | Shares | $2.8M | 265K |
| Arrivent Biopharma Inc | AVBP | Call | $2.5M | 110K |
| Sol-Gel Technologies Ltd | Shares | $2.5M | 31K | |
| Pasithea Therapeutics Corp | KTTA | Shares | $1.6M | 2.1M |
| Relay Therapeutics Inc | RLAY | Call | $1.5M | 150K |
| Traws Pharma Inc | TRAW | Shares | $936K | 512K |
| Zentalis Pharmaceuticals Inc | ZNTL | Call | $936K | 400K |
| Therapeuticsmd Inc | TXMD | Shares | $849K | 420K |
| Spruce Biosciences Inc | SPRB | Shares | $797K | 12K |
| Werewolf Therapeutics Inc | HOWL | Shares | $469K | 564K |
| Neuphoria Therapeutics Inc | NEUP | Shares | $312K | 77K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.